Literature DB >> 23919091

Discrimination of Enterobacteriaceae and Non-fermenting Gram Negative Bacilli by MALDI-TOF Mass Spectrometry.

Reiner Schaumann1, Nicolas Knoop, Gelimer H Genzel, Kevin Losensky, Christiane Rosenkranz, Catalina S Stîngu, Wolfgang Schellenberger, Arne C Rodloff, Klaus Eschrich.   

Abstract

Discrimination of Enterobacteriaceae and Non-fermenting Gram Negative Bacilli by MALDI-TOF Mass Spectrometry Matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) has proven to be an effective identification tool in medical microbiology. Discrimination to subspecies or serovar level has been found to be challenging using commercially available identification software. By forming our own reference database and using alternative analysis methods, we could reliably identify all implemented Enterobacteriaceae and non-fermenting gram negative bacilli by MALDI-TOF MS and even succeeded to distinguish Shigella sonnei from Escherichia coli (E. coli) and Salmonella enterica spp. enterica serovar Enteritidis from Salmonella enterica spp. enterica serovar Typhimurium. Furthermore, the method showed the ability to separate Enterohemorrhagic E. coli (EHEC) and Enteropathogenic E. coli (EPEC) from non-enteropathogenic E. coli.

Entities:  

Keywords:  E. coli; EHEC; EPEC; Enterobacteriaceae; MALDI-TOF MS; Salmonella spp; Shigella sonnei.

Year:  2013        PMID: 23919091      PMCID: PMC3722536          DOI: 10.2174/1874285801307010118

Source DB:  PubMed          Journal:  Open Microbiol J        ISSN: 1874-2858


Since matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) has become a more and more effective tool for species identification in clinical microbiology [1-4], many studies tried to evaluate its performance compared to conventional phenotypic and genotypic identification systems [5-11]. Especially by using commercially available MALDI-TOF MS data analysis software, satisfying results in the discrimination of predominantly gram negative bacilli were achieved. Some authors already encountered difficulties in the discrimination of closely related species and began to develop alternative, not commercially available, analysis software. In order to optimize reliable discrimination we evaluated the performance of MALDI-TOF MS in the identification of gram negative bacilli based on a database containing strains previously identified by the API systems (bioMérieux S.A., Marcy L’Etoile, France) and checked reproducibility in a blindfolded study with strains previously identified by the VITEK II system (bioMérieux S.A.). Both tools are widely spread standard identification systems for bacteria [12]. As already indicated above, the aim of our study was not only to discriminate between genetically distinct species, but also between closely related species like E. coli and Shigella sonnei or Salmonella enterica spp. enterica serovars Enteritidis and Typhimurium which so far need additional tests such as agglutination reactions for definite species identification. He et al. investigated the performance of the Biotyper software (Bruker Daltonics, Germany) in the identification of enteric bacterial pathogens and failed to distinguish Shigella spp. and Enterohemorrhagic E. coli (EHEC) from non-enteropathogenic E. coli [9]. Dieckmann et al. demonstrated a reliable method to distinguish strains of Salmonella enterica to the subspecies level, but not yet different serovars [5]. Karger et al. applied a method comparable to the one used by the aforementioned author to discriminate between shiga toxin producing serotypes of E. coli and encountered difficulties in finding optimal data analysis parameters allowing no reproducible and reliable discrimination [11]. Since we already achieved good results by using our own, alternative statistical analysis software in recent studies [13-15], we attempted to optimize identification rates for gram negative bacilli by MALDI-TOF MS by establishing our own database of gram negative bacilli with a total of 219 strains from 17 species and 12 genera. Fifteen species of Enterobacteriaceae and 2 species of non-fermenting gram negative bacilli were included (Table ). As proposed by Seng et al. [7], we established spectra of about 10 strains as a reference for each species in the database (for illustration see Fig. ). Those strains were clinical isolates from the routine diagnostics laboratory of our institute. Previous identification of the implemented strains from clinical specimens was conducted in a standard manner beginning with microbiological culture which yielded pure growth of lactose non-fermenting and fermenting Gram negative rods (selective medium Endo-Agar (bioMérieux S.A.). The strains were further identified by Gram stain and key reactions, i.e. KOH, indole, oxidase as well as with commercially available API systems (API 20 E, ID 32 E, ID 32 GN and API 20 NE, bioMérieux S.A.). Organisms identified as Salmonella spp. (lactose negative) were subjected to subsequent serovar determination by serotyping agglutination according to the Kauffmann-White scheme using Salmonella antisera from Sifin (SIFIN Institut für Immunpräparate und Nährmedien GmbH, Berlin, Germany). Any inconsistent specimens were identified genotypically by 16S rDNA amplification which was performed with the primers 609V and 699R as described by Ackermann et al. [16] resulting in a PCR product of approx. 300 bp. Amplification sequences were compared using the NCBI BLAST database (http://www.ncbi.nlm.nih.-gov/blast/Blast.cgi). All strains were isolated from clinical specimens, including blood cultures, wound swabs, urine, stool and specimens from the respiratory tract, i.e. sputum, tracheal aspirate, bronchoalveolar lavage (BAL) and tissue specimens. The following reference strains were used to validate appropriate species affiliation of the clinical samples: E. coli ATCC 25922, E. coli GSM 2163, Klebsiella pneumoniae (K. pneumoniae) 911 (a strain from an interlaboratory test in Germany) and Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853. To check the accuracy of our database and to evaluate MALDI-TOF MS discrimination potential compared to another phenotypic detection system (VITEK II), 99 strains isolated from clinical specimens (blood cultures, wound swabs, urine, stool and specimens from the respiratory tract, i.e. sputum, tracheal aspirate, broncheoalveolar lavage and tissue specimens) and routinely identified by VITEK II in our lab were subjected to MALDI-TOF MS analysis in a blindfolded manner. In order to analyze bacterial specimens by MALDI-TOF MS, multiple colonies from a pure culture were transferred to plastic tubes and cell lysis was conducted with trifluoroacetic acid (Merck, Darmstadt, Germany). The centrifuged cell lysates were brought to MALDI-TOF MS stainless steel target plates after vacuum centrifugation and α-cyano-4-hydroxycinnamic acid (Bruker Daltonics, Bremen, Germany) was used as a matrix [15]. MALDI-TOF MS spectra were acquired with a Bruker Autoflex II mass spectrometer (Bruker Daltonics, Germany) with a nitrogen laser (λ=337nm) operated in the positive linear mode (delay 350ns, voltage 20 kV; mass over charge ratio (m/z) ranging from 2,000 to 12,000) under control of FlexControl software (version 2.4; Bruker Daltonics). Each spectrum was obtained by averaging 500 laser shots acquired in automatic mode at the minimum laser power being necessary for ionization of the samples. The calibration strain for each MALDI-TOF MS optical measurement was E. coli GSM 2163 from New England BioLabs. Data files were transferred to FlexAnalysis software (version 2.4; Bruker Daltonics) for automated peak extraction. With this software, 50 peaks were automatically labeled in each spectrum according to their appearance above the background (threshold ratio 1.5). Correct labeling was controlled manually. Peak lists containing masses and intensities were exported as Excel-files [14, 15]. The data analysis was not performed by the Biotyper system provided by Bruker Daltonics, but by MatLab based algorithms (Version 7.10.0.499; The Math-Works Inc., Natick, MA) which were edited at the Institute of Biochemistry [14, 15]. Thus, peaks from all spectra belonging to one species were aligned to species-specific peak-clusters by forming mass-dependent windows over the peaks, taking the strain- and recording-specific variations of peak masses into account. Statistical similarity analysis was carried out by hierarchical clustering and dendrograms ware calculated on the basis of distance matrices by using a complete linkage function. For closely related species, we used classification algorithms, based on support-vector-machines (SVM) featuring an efficient two class classification. This was achieved by training the algorithm with a set of spectra of bacteria of known identity, according to our reference database. An error estimate of the class prediction was carried out by calculation of a 10-fold cross-validation error for the training group. For this purpose, the training set was first divided into 10 subsets of equal size. Sequentially, one subset was tested by using the classifier trained on the remaining nine subsets. Thus, each probe of the training set was predicted once. The cross-validation accuracy is the percentage of data which were correctly classified (correct rate) [14, 15]. While establishing the reference database we soon achieved excellent results in discriminating the species from one another by using statistical similarity analysis software. SVM algorithms were necessary for the separation of E. coli and Shigella sonnei and the two salmonella serovars. In some cases Enterobacter cloacae (E. cloacae) clustered together with E. coli and Shigella sonnei – in those cases SVM application could also resolve the discrepancies. In order to proof our results while establishing the database we subjected the 99 strains identified by VITEK II to MALDI-TOF MS identification. The blindfolded study showed that MALDI-TOF MS could correctly identify 95% of the strains according to the previous VITEK II identification. Four strains were misidentified: one K. pneumoniae as E. coli (S36), one Enterobacter aerogenes (E. aerogenes) as Serratia marcescens (S. marcescens) (S37), one E. cloacae as E. coli (S89), and one Shigella sonnei as E. coli (S67). The four strains were subsequently subjected to API identification and 16s rDNA sequencing to resolve the discrepancies. By this re-testing procedure isolate S37 was identified as S. marcescens and isolate S67 as Shigella sonnei. The two remaining misidentified specimen could not be identified unequivocally and were excluded from our study. In conclusion, a correct identification rate of 99% was achieved. Even Shigella sonnei was correctly distinguished from E. coli in 4 of 5 cases and the closely related S. enterica spp. enterica serovar Enteritidis and S. enterica spp. enterica serovar Typhimurium were properly identified (Table ). Table illustrates our results in the identification by MALDI-TOF MS compared to the VITEK II machine. As inconsistencies have arisen, those specimens were identified by another biochemical method (API) or even by serological and genotypic methods as mentioned above. The third column illustrates the results after the second identification (re-testing). The correct identification rate is calculated on the match after the re-testing. In addition, we evaluated the performance of our analysis software in the discrimination of non-enteropathogenic E. coli from its pathotypes Enteropathogenic E. coli (EPEC) and Enterohemorrhagic E. coli (EHEC), respectively. Spectra of 12 EPEC and 7 EHEC strains, previously identified by genotypic systems as mentioned above [16] and according to Hauswaldt et al. [17] (also including Endo-Agar selective growth and beta-lactamase screening by Etest (AB bioMérieux, Solna, Sweden)), were acquired. Further analysis was conducted as described for the aforementioned study. Definite discrimination was achieved by using SVM algorithms, where one class was defined by the known spectra of non-enteropathogenic E. colis from our database and the other by those of one of the pathotypes, respectively. The classification resulted in a correct rate of 96% for EHEC and a correct rate of 97% for EPEC indicating a reliable discrimination of the two pathotypes from non-enteropathogenic E. coli.

CONCLUSION

Our results show that MALDI-TOF MS has a definite potential to distinguish closely related species and subspecies of Enterobacteriaceae from one another. As we could already indicate for the future detection of antibiotic resistance in Enterobacteriaceae and P. aeruginosa, powerful statistical classification algorithms even manage to distinguish between closely related serovars and serotypes of Enterobacteriaceae. Therefore, further improvement of data analysis software and the continuous acquisition of new reference spectra are of outstanding importance. The lack of specific reference spectra, especially of clinical isolates and genetically closely related specise, depicts an issue of the Biotyper database that other authors [5, 9] have encountered before. The variation of parameters in the statistical analysis also constitutes a burden for the implementation of MALDI-TOF MS in routine diagnostics for closely related serotypes or serovars of one species as indicated by Karger et al. for shiga toxin producing E. coli serotypes [11]. Thus it is preferable to conjoin multi-central acquired reference spectra and experience in the statistical analysis of the latter to form a reliable and powerful identification tool for routine microbiological diagnostics.
Table 1.

Formation of Our Database

SpeciesStrains (n)Spectra (n) *
Escherichia coli19148
Klebsiella pneumoniae19136
Klebsiella oxytoca1080
Enterobacter cloacae19146
Enterobacter aerogenes972
Proteus mirabilis20152
Proteus vulgaris1078
Salmonella Enteritidis1080
Salmonella Typhimurium1080
Serratia marcescens1080
Shigella sonnei971
Yersinia enterocolitica970
Citrobacter freundii1077
Morganella morganii857
Acinetobacter baumanii1080
Pseudomonas aeruginosa37219
Total2191626

Multiple spectra from a total of four specimens per each single strain were acquired at two distinct dates to check reproducibility and taking strain and recording specific variations into account.

Table 2.

Results of the Blindfolded Study

SpeciesStrains Identified by MALDI-TOF MS (n)Strains Routinely Identified by VITEK II (n)Strains Correctly Identified by MALDI-TOF MS After Re-testing (n)Strains Correctly Identified by MALDI-TOF MS (%)
Escherichia coli6/6100
Klebsiella pneumoniae5/65/51100
Klebsiella oxytoca6/6100
Enterobacter cloacae5/65/51100
Enterobacter aerogenes5/65/51100
Proteus mirabilis6/6100
Proteus vulgaris7/7100
Salmonella Enteritidis5/5100
Salmonella Typhimurium6/6100
Serratia marcescens7/78/82100
Shigella sonnei4/54/580
Yersinia enterocolitica6/6100
Citrobacter freundii7/7100
Morganella morganii7/7100
Acinetobacter baumanii7/7100
Pseudomonas aeruginosa6/6100
Total95/9927/2899

One strain was excluded due to ambiguous identification

One strain was previously misidentified by VITEK II as E. aerogenes. The strain was identified by re-testing as S. marcescens, implicating now a total amount of eight S. marcescens in the study.

  16 in total

1.  Microorganism identification by mass spectrometry and protein database searches.

Authors:  P A Demirev; Y P Ho; V Ryzhov; C Fenselau
Journal:  Anal Chem       Date:  1999-07-15       Impact factor: 6.986

Review 2.  Characterization of intact microorganisms by MALDI mass spectrometry.

Authors:  C Fenselau; P A Demirev
Journal:  Mass Spectrom Rev       Date:  2001 Jul-Aug       Impact factor: 10.946

Review 3.  Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli.

Authors:  Caroline M O'hara
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Authors:  Piseth Seng; Michel Drancourt; Frédérique Gouriet; Bernard La Scola; Pierre-Edouard Fournier; Jean Marc Rolain; Didier Raoult
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

5.  Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry.

Authors:  R D Holland; J G Wilkes; F Rafii; J B Sutherland; C C Persons; K J Voorhees; J O Lay
Journal:  Rapid Commun Mass Spectrom       Date:  1996       Impact factor: 2.419

6.  Detection of pathogenic and non-pathogenic bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  T Krishnamurthy; P L Ross; U Rajamani
Journal:  Rapid Commun Mass Spectrom       Date:  1996       Impact factor: 2.419

7.  Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.

Authors:  G Ackermann; Y J Tang; R Kueper; P Heisig; A C Rodloff; J Silva; S H Cohen
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

8.  Determination of serotypes of Shiga toxin-producing Escherichia coli isolates by intact cell matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Axel Karger; Mario Ziller; Barbara Bettin; Birgit Mintel; Susann Schares; Lutz Geue
Journal:  Appl Environ Microbiol       Date:  2010-11-29       Impact factor: 4.792

9.  Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria.

Authors:  A Mellmann; J Cloud; T Maier; U Keckevoet; I Ramminger; P Iwen; J Dunn; G Hall; D Wilson; P Lasala; M Kostrzewa; D Harmsen
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

10.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of clinically relevant bacteria.

Authors:  Cinzia Benagli; Viviana Rossi; Marisa Dolina; Mauro Tonolla; Orlando Petrini
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

View more
  5 in total

1.  Species identification of strains belonging to genus Citrobacter using the biochemical method and MALDI-TOF mass spectrometry.

Authors:  Renáta Kolínská; Petra Spanělová; Michal Dřevínek; Jaroslav Hrabák; Helena Zemličková
Journal:  Folia Microbiol (Praha)       Date:  2014-08-13       Impact factor: 2.099

2.  Performance of mass spectrometric identification of bacteria and yeasts routinely isolated in a clinical microbiology laboratory using MALDI-TOF MS.

Authors:  Weiping Wang; Haiyan Xi; Mei Huang; Jie Wang; Ming Fan; Yong Chen; Haifeng Shao; Xiaojun Li
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

3.  Use of MALDI-TOF MS for Identification of Nontuberculous Mycobacterium Species Isolated from Clinical Specimens.

Authors:  María Concepción Mediavilla-Gradolph; Inmaculada De Toro-Peinado; María Pilar Bermúdez-Ruiz; María de los Ángeles García-Martínez; María Ortega-Torres; Natalia Montiel Quezel-Guerraz; Begoña Palop-Borrás
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

4.  Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot.

Authors:  Márió Gajdács; Edit Urbán
Journal:  Health Serv Res Manag Epidemiol       Date:  2019-08-15

5.  Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot.

Authors:  Márió Gajdács; Katalin Burián; Gabriella Terhes
Journal:  Antibiotics (Basel)       Date:  2019-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.